These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14551402)

  • 1. Racial disparities in receipt of secondary stroke prevention agents among US nursing home residents.
    Christian JB; Lapane KL; Toppa RS
    Stroke; 2003 Nov; 34(11):2693-7. PubMed ID: 14551402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical correlates and drug treatment of residents with stroke in long-term care.
    Quilliam BJ; Lapane KL
    Stroke; 2001 Jun; 32(6):1385-93. PubMed ID: 11387503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Warfarin use in nursing home residents: results from the 2004 national nursing home survey.
    Ghaswalla PK; Harpe SE; Slattum PW
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):25-36.e2. PubMed ID: 22226690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial disparities in end-of-life planning and services for deceased nursing home residents.
    Frahm KA; Brown LM; Hyer K
    J Am Med Dir Assoc; 2012 Nov; 13(9):819.e7-11. PubMed ID: 22959732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with the initiation and discontinuation of secondary stroke prevention agents in nursing homes.
    Hughes CM; Lapane KL
    J Stroke Cerebrovasc Dis; 2004; 13(4):164-70. PubMed ID: 17903970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of antiplatelet and anticoagulant agents on risk of hospitalization for bleeding among a population of elderly nursing home stroke survivors.
    Quilliam BJ; Lapane KL; Eaton CB; Mor V
    Stroke; 2001 Oct; 32(10):2299-304. PubMed ID: 11588317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of warfarin use in atrial fibrillation patients in the inpatient setting.
    Agarwal S; Bennett D; Smith DJ
    Am J Cardiovasc Drugs; 2010; 10(1):37-48. PubMed ID: 20104933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and the factors associated with oral anticoagulant use among nursing home residents.
    Chen Q; Lapane K; Nunes AP; Tjia J; Hugunin J; Alcusky M
    J Clin Pharm Ther; 2021 Dec; 46(6):1714-1728. PubMed ID: 34463969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial/Ethnic differences in ischemic stroke rates and the efficacy of warfarin among patients with atrial fibrillation.
    Shen AY; Yao JF; Brar SS; Jorgensen MB; Wang X; Chen W
    Stroke; 2008 Oct; 39(10):2736-43. PubMed ID: 18635860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Did the introduction of a prospective payment system for nursing home stays reduce the likelihood of pharmacological management of secondary ischaemic stroke?
    Lapane KL; Hughes CM
    Drugs Aging; 2006; 23(1):61-9. PubMed ID: 16492070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of antithrombotic usage for atrial fibrillation in aged care facilities.
    Singh P; Arrevad PS; Peterson GM; Bereznicki LR
    J Clin Pharm Ther; 2011 Apr; 36(2):166-71. PubMed ID: 21366645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial and ethnic disparities in the pharmacologic management of diabetes mellitus among long-term care facility residents.
    Allsworth JE; Toppa R; Palin NC; Lapane KL
    Ethn Dis; 2005; 15(2):205-12. PubMed ID: 15825966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the combination of warfarin and aspirin have a place in secondary stroke prevention? Yes.
    Furlan AJ
    Stroke; 2009 May; 40(5):1942-3. PubMed ID: 19299635
    [No Abstract]   [Full Text] [Related]  

  • 14. Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?
    Usman MH; Notaro LA; Nagarakanti R; Brahin E; Dessain S; Gracely E; Ezekowitz MD
    Am J Cardiol; 2009 Apr; 103(8):1107-12. PubMed ID: 19361598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of warfarin therapy among residents who developed venous thromboembolism in the nursing home.
    Reardon G; Pandya N; Nutescu EA; Lamori J; Damaraju CV; Schein J; Bookhart BK
    Am J Geriatr Pharmacother; 2012 Dec; 10(6):361-72. PubMed ID: 23217529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic drugs for prevention of recurrent stroke.
    Pettigrew LC; Williams SC
    J Ky Med Assoc; 2002 May; 100(5):184-93. PubMed ID: 12040909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction.
    Buresly K; Eisenberg MJ; Zhang X; Pilote L
    Arch Intern Med; 2005 Apr; 165(7):784-9. PubMed ID: 15824298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of warfarin therapy for residents in long-term care who have atrial fibrillation.
    Patel AA; Reardon G; Nelson WW; Philpot T; Neidecker MV
    Clin Ther; 2013 Nov; 35(11):1794-804. PubMed ID: 24139051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The costs of warfarin underuse and nonadherence in patients with atrial fibrillation: a commercial insurer perspective.
    Casciano JP; Dotiwala ZJ; Martin BC; Kwong WJ
    J Manag Care Pharm; 2013 May; 19(4):302-16. PubMed ID: 23627576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiplatelet drugs in cardiovascular prevention: stroke: acute phase and secondary prevention.
    Prescrire Int; 2000 Jun; 9(47):85-7. PubMed ID: 11010750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.